| 临床相关特征 | 单因素分析 | 多因素分析 | ||
| OR(95% CI) | P值 | OR(95% CI) | P值 | |
| 接种疫苗后天数 | 0.986 (0.974~0.998) | 0.024 | 0.996 (0.981~1.010) | 0.583 |
| 年龄(岁) | 0.969 (0.936~1.002) | 0.070 |
|
|
| 体重指数(kg/m2) | 0.986 (0.877~1.112) | 0.821 |
|
|
| 疫苗类型 |
|
|
|
|
| BBIBP-CorV | Ref |
|
|
|
| CoronaVac | 0.492 (0.224~1.073) | 0.074 |
|
|
| Zhifei Longcom, China | 0.387 (0.147~1.031) | 0.060 |
|
|
| 性别 |
|
|
|
|
| 女性 | Ref |
|
|
|
| 男性 | 1.519 (0.734~3.110) | 0.250 |
|
|
| TNM分期 |
|
|
|
|
| TNM1 | Ref |
|
|
|
| TNM2 | 0.976 (0.362~2.469) | 0.961 |
|
|
| TNM3 | 1.105 (0.342~3.574) | 0.865 |
|
|
| TNM4 | 1.094 (0.295~4.325) | 0.893 |
|
|
| ASA分级 |
|
|
|
|
| ASA1 | Ref |
|
|
|
| ASA2 | 0.460 (0.096~1.661) | 0.269 | 0.772 (0.152~3.103) | 0.729 |
| ASA3 | 0.129 (0.029~0.408) | <0.01 | 0.180 (0.038~0.625) | 0.013 |
| 积极治疗 |
|
|
|
|
| No | Ref |
|
|
|
| Yes | 0.228 (0.081~0.548) | <0.01 | 0.465 (0.145~1.358) | 0.173 |
| 化疗 |
|
|
|
|
| No | Ref |
|
|
|
| Yes | 0.197 (0.092~0.407) | <0.01 | 0.267 (0.107~0.634) | <0.01 |
| 红细胞计数(1012/L) | 0.992 (0.602~1.632) | 0.974 |
|
|
| 白细胞计数(109/L) | 0.983 (0.882~1.103) | 0.763 |
|
|
| 淋巴细胞计数(109/L) | 0.839 (0.487~1.028) | 0.502 |
|
|
| 白蛋白(g/L) | 1.000 (0.999~1.000) | 0.826 |
|
|
| RBD特异性B细胞 | 1.025 (0.974~1.083) | 0.348 |
|
|
| 静息B细胞 | 1.008 (0.973~1.046) | 0.638 |
|
|
| 中间B细胞 | 0.983 (0.958~1.008) | 0.188 |
|
|
| 活化B细胞 | 1.012 (0.972~1.057) | 0.543 |
|
|
| 非典型B细胞 | 1.017 (0.983~1.055) | 0.341 |
|
|